Upcoming Investor Conferences for Travere Therapeutics
Travere Therapeutics, Inc. (NASDAQ: TVTX), is gearing up for an exciting month as company management prepares to showcase their latest endeavors at notable investor conferences. These events are critical for connecting with stakeholders and presenting valuable insights into the company's innovative work.
Key Conferences Scheduled
This November, Travere Therapeutics will be featured in the following prominent conferences:
Guggenheim Securities Healthcare Innovation Conference
On November 11, the company will present at the Guggenheim Securities Healthcare Innovation Conference. This event promises to be a great platform for discussing advancements within the healthcare sector, focusing on innovative therapies designed for rare diseases.
Jefferies London Healthcare Conference
Following the Guggenheim event, Travere will participate in the Jefferies London Healthcare Conference on November 20. This global conference attracts key investors and thought leaders in healthcare, fostering discussions that can drive the future of pharmaceutical advancements.
Accessing the Presentations
For those interested in hearing the presentations live, webcasts will be streamed on the Investor Relations page of Travere's official website. Attendees can also access recordings of the talks for up to 30 days after the events, ensuring widespread access to important information.
About Travere Therapeutics
At the heart of Travere Therapeutics lies a deep commitment to the rare disease community. The company aims to improve the lives of patients affected by rare conditions through innovative biopharmaceutical solutions. By prioritizing the needs and experiences of patients, Travere continuously endeavors to develop impactful treatments that resonate with those they serve.
Company Contact Information
For inquiries, Travere Therapeutics encourages stakeholders to reach out via their dedicated contact channels. Investors can connect by calling 888-969-7879 or emailing IR@travere.com. Similarly, media inquiries can be directed to the same number or via email at mediarelations@travere.com.
Frequently Asked Questions
What are the key dates for Travere's upcoming conferences?
Travere will present at the Guggenheim Securities Healthcare Innovation Conference on November 11 and at the Jefferies London Healthcare Conference on November 20.
Where can I watch the webcasts of the presentations?
The webcasts will be available on Travere's Investor Relations page on their official website.
Why is Travere Therapeutics participating in these conferences?
The conferences provide an essential opportunity for Travere to share insights on their innovative therapies and engage with stakeholders.
How does Travere support rare disease patients?
Travere is dedicated to understanding the needs of rare disease patients and delivering effective treatments that cater to their unique challenges.
What contact methods are available for investors and media?
Investors can contact Travere via phone or email, and media inquiries can also be directed to the same contact points.